Jefferies Financial Group upgraded shares of Enhabit (NYSE:EHAB – Free Report) from a hold rating to a buy rating in a research report sent to investors on Monday morning, Marketbeat.com reports. They currently have $9.50 price objective on the stock, up from their prior price objective of $8.25.
Separately, Leerink Partners reissued a “market perform” rating and set a $8.00 price target (down previously from $8.50) on shares of Enhabit in a report on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $9.40.
Get Our Latest Research Report on EHAB
Enhabit Trading Up 13.2 %
Enhabit (NYSE:EHAB – Get Free Report) last announced its earnings results on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The business had revenue of $253.60 million during the quarter, compared to analyst estimates of $261.69 million. During the same period in the previous year, the firm earned $0.03 earnings per share. On average, research analysts predict that Enhabit will post 0.22 EPS for the current year.
Institutional Investors Weigh In On Enhabit
Hedge funds have recently modified their holdings of the stock. Jane Street Group LLC boosted its holdings in Enhabit by 514.3% in the 3rd quarter. Jane Street Group LLC now owns 901,084 shares of the company’s stock worth $7,119,000 after acquiring an additional 754,395 shares during the period. Marshall Wace LLP purchased a new position in shares of Enhabit in the second quarter valued at $1,941,000. Systematic Financial Management LP grew its holdings in Enhabit by 12.2% during the 3rd quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company’s stock valued at $14,522,000 after purchasing an additional 199,235 shares in the last quarter. DekaBank Deutsche Girozentrale increased its stake in Enhabit by 52.3% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 518,412 shares of the company’s stock worth $4,306,000 after buying an additional 178,000 shares during the period. Finally, Bardin Hill Management Partners LP lifted its holdings in Enhabit by 927.4% in the 3rd quarter. Bardin Hill Management Partners LP now owns 174,304 shares of the company’s stock worth $1,377,000 after buying an additional 157,338 shares in the last quarter.
About Enhabit
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
Recommended Stories
- Five stocks we like better than Enhabit
- What is the Hang Seng index?
- How to Master Trading Discipline: Overcome Emotional Challenges
- ESG Stocks, What Investors Should Know
- Does China Investigation Change NVIDIA’s Outlook; Yes, No, Maybe?
- Consumer Staples Stocks, Explained
- Is Marvell Technology Chipping Away at NVIDIA’s Market Lead?
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.